calendar
4,497 catalysts · 3,230 8k filing · 577 earnings · 231 grant · 172 phase 2 completion · 167 approval · 133 drug shortage
next 91 dayslessmore
MonWedFri
4,497 catalysts · 3,230 8k filing · 577 earnings · 231 grant · 172 phase 2 completion · 167 approval · 133 drug shortage
AI grant. $490,611. PI: Aaron Silva-Sanchez
ES grant. $354,375. PI: YIFANG ZHU
ES grant. $2,864,424. PI: Jordan Adam Bisanz
GM grant. $406,037. PI: Brian Clowers
GM grant. $417,845. PI: Jian Xie
EB grant. $134,902. PI: Mark Vincent Albert
GM grant. $418,822. PI: Gavin McLean King
GM grant. $413,946. PI: Rebecca Beth Berlow
GM grant. $412,632. PI: Kyle Cottrell
EB grant. $10,000. PI: Mini Das
Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL
Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: MICRO LABS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MICRO LABS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: BIOCON PHARMA. Form: TABLET. Route: ORAL
Sponsor: MSN. Form: TABLET. Route: ORAL
Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET
Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: INVENTIA. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: AIZANT. Form: TABLET. Route: ORAL
Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION
Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL
Sponsor: MSN. Form: TABLET. Route: ORAL
Sponsor: CIPLA. Form: TABLET. Route: ORAL
Sponsor: CIPLA LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: TORRENT. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ALEMBIC. Form: TABLET. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LUPIN LTD. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS USA INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: CIPLA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional
Product code: QRC. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: LNH. Advisory committee: Radiology. Type: Traditional
Product code: IYN. Advisory committee: Radiology. Type: Traditional
Product code: IXI. Advisory committee: Radiology. Type: Traditional